First-of-its-kind Smart monitoring technology launches
Managing the risks associated with Industrial Hygiene and Quality and meeting operational efficiency targets.
Powder containment and aseptic transfer valve specialist, ChargePoint Technology, has launched a unique Smart monitoring hub to support efficiency and safety within chemical and pharmaceutical manufacturing processes. The company will be exhibiting its new VERIFI solution at ACHEMA 2018
ChargePoint contained transfer devices are critical to ensuring integrity of product handling during high potency and sterile manufacturing, enabling manufacturers to meet their product quality, operator safety and productivity targets. Now, with VERIFI, manufacturers have an automatic/reliable method of understanding the health status of the device allowing them to better control risk and ensure consistent integrity throughout the life-cycle of the system and its critical components.
VERIFI is connected directly onto the ChargePoint Active valve unit so continuously records data and delivers alerts to its users. Its LED display provides operators with visual feedback, giving the user confidence and safety and quality teams peace of mind. Service advice allows maintenance teams to take preventative action, resulting in less downtime and improved efficiency.
Data can also be synchronised via WIFI to the secure VERIFI Portal, where data is stored in the cloud for production and process managers to analyse remotely and export for further reporting.
Ben Wylie, Product and Channel Marketing Manager of ChargePoint said: “Meeting the increasing pressures that exist in a production environment can be a challenge, including not only managing the risks associated with Industrial Hygiene and Quality but also meeting operational efficiency targets too”.
“This unique technology that we are launching reinforces our commitment to continuously adapting to market challenges and offering such advancements to our customers is something that we are extremely proud of. We have experienced a growing demand for our containment technologies globally over the past 12 months. As the ‘biotech boom’ and the use of high potency APIs continues, we can continue to invest in this market, offering safe and efficient material transfer solutions.
“Not only are we seeing enormous support for our new monitoring technology but our split butterfly valve (SBV) is growing in popularity worldwide, with the industry adopting it as an alternative to more cumbersome and costly containment solutions.”
ChargePoint Technology’s other solutions include its AseptiSafe range providing increased sterility assurance for ingredient and small component transfers in aseptic processing and sterile API production. The PharmaSafe powder containment valves offer the highest level of containment performance to ensure the safe handling of potent APIs, intermediates and pharmaceutical formulations.
Related News
-
News CPHI Frankfurt: Interview with Marcelo Cruz, Vice President, Business Development & Marketing at Tjoapack
In this series of interviews, we caught up with some of the exhibitors at CPHI Frankfurt to discover what innovations are being brought to the pharmaceutical industry this year. Here we chat with Marcelo Cruz of Tjoapack to discuss how global events ar... -
News CPHI Frankfurt 2022: Innovator Interviews – Bioiberica
In this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We caught up with Mónica Gómez Navarro (Marketing Manager Branded Ingredients), ... -
News CPHI Frankfurt 2022: Innovator Interview – Procaps Group
In this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We interviewed Rosella Del Vecchio Herrera, Marketing Director at Procaps Group, to discover h... -
News From the floor - CPHI Frankfurt 2022
The live blog from the people on the ground at CPHI Frankfurt - covering all stand-out news, memorable moments, and keynote updates from the 2022 event. -
News How to Commercialise an Advanced Therapy: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Andrea Zobel, Senior Director, Personalized Supply Chain at World Courier (Berlin Germany), Melissa Lattanzi, VP Emerging Therapies at AmerisourceBergen (King of Prussia, USA), and Hans-Peter Scherzer, Customer Suc... -
News CDMO - Health is a Joint Project: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Emanuele Agnese, Business Development Manager and Pietro Allegrini, R&D Director at Indena, present the ways in which a reliable manufacturing partner in the pursuit of better health outcomes for patients and pharm... -
News Streamlined Development for Efficient Production of Bispecific Molecules: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Séverine Fagète, VP, Cell Line Development Services at Selexis (Geneva, Switzerland), and Brandon Brino (Durham, USA), Process Development Scientist and Group Leader at KBI Biopharma, present an overv... -
News MDR – How to collect post-market clinical follow-up data (PMCF): Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Philipp Annecke, Junior Key Account Manager and Heinrich Martens, VP Regulatory Affairs of Fresenius Kabi (Bad Homburg, Germany) present guidances from the Medical Devices Regulation on clinical data evaluatio...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance